{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2008"],"condition":["Colorectal Carcinoma","Colorectal Tumors","Neoplasms, Colorectal","Rectal Neoplasms","Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Carcinoma","Colorectal Tumors","Neoplasms, Colorectal","Rectal Neoplasms","Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2057411"],"location":["Netherlands"],"study_start_month":["9"],"keyword":["Radiosensitivity","Locally advanced rectal cancer","Chemoradiation","Nelfinavir"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Nelfinavir, a Phase I/Phase II Rectal Cancer Study","description":"The aim is to study safety and activity of nelfinavir , added to standard chemoradiotherapy in patients with locally advanced rectal cancer. Furthermore analysis of the effect of nelfinavir combined with chemoradiation on tumour tissue will be studied","dates":{"creation":"2008-09-15"},"accession":"2057411","cross_references":{"ClinicalTrials___gov":["NCT00704600"]}}